Articles by Mark Rosolowsky - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Mark Rosolowsky

Mark Rosolowsky


Mark Rosolowsky is the executive director of global regulatory sciencesCMC at Bristol Myers Squibb

Articles
Quality by Design for Biotechnology Products—Part 3
January 1, 2010

Regulatory flexibility can make continuous improvement possible.

Quality by Design for Biotechnology Products—Part 2
December 1, 2009

Second in a three-part series that discusses the complexities of QbD implementation in biotech development.

Quality by Design for Biotechnology Products—Part 1
November 1, 2009

First in a three-part series that discusses the complexities of QbD implementation in biotech product development.

ADVERTISEMENT

ADVERTISEMENT

Click here